Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Therapeutic immunology

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Therapeutic Immunology|August 1, 1995
Rational development of tumour antigen-specific immunization in melanomaT F Gajewski, F Fallarino
Therapeutic Immunology|January 1, 1994
Interaction of tumour necrosis factor-alpha and radiation against human colon tumour cellsD S Gridley, W C Glisson, J R Uhm
Therapeutic Immunology|April 1, 1994
Interleukin-I antagonistsS K Dower, W Fanslow, C Jacobs, et al.
Therapeutic Immunology|April 1, 1994
Lymphocyte development in genetically manipulated miceN Killeen, D R Littman
Therapeutic Immunology|April 1, 1994
Human recombinant TNF-alpha on localization of 90Y-radioantibody in human tumour xenograftsT Matsushita, T W Griffin, Z Yao, et al.
Therapeutic Immunology|June 1, 1994
Blocking of adhesion molecules in vivo as anti-inflammatory therapyP A Ward, M S Mulligan
Therapeutic Immunology|August 1, 1994
The CD28 costimulatory pathwayH T Leung, P S Linsley
Therapeutic Immunology|October 1, 1994
Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysisJ Greenwood, S D Gorman, E G Routledge, et al.
Therapeutic Immunology|December 1, 1994
Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodiesJ D Isaacs, H Waldmann
Therapeutic Immunology|December 1, 1994
Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokinesI C Abbs, M Clark, H Waldmann, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Therapeutic Immunology|August 1, 1995
Rational development of tumour antigen-specific immunization in melanomaT F Gajewski, F Fallarino
Therapeutic Immunology|January 1, 1994
Interaction of tumour necrosis factor-alpha and radiation against human colon tumour cellsD S Gridley, W C Glisson, J R Uhm
Therapeutic Immunology|April 1, 1994
Interleukin-I antagonistsS K Dower, W Fanslow, C Jacobs, et al.
Therapeutic Immunology|April 1, 1994
Lymphocyte development in genetically manipulated miceN Killeen, D R Littman
Therapeutic Immunology|April 1, 1994
Human recombinant TNF-alpha on localization of 90Y-radioantibody in human tumour xenograftsT Matsushita, T W Griffin, Z Yao, et al.
Therapeutic Immunology|June 1, 1994
Blocking of adhesion molecules in vivo as anti-inflammatory therapyP A Ward, M S Mulligan
Therapeutic Immunology|August 1, 1994
The CD28 costimulatory pathwayH T Leung, P S Linsley
Therapeutic Immunology|October 1, 1994
Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysisJ Greenwood, S D Gorman, E G Routledge, et al.
Therapeutic Immunology|December 1, 1994
Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodiesJ D Isaacs, H Waldmann
Therapeutic Immunology|December 1, 1994
Sparing of first dose effect of monovalent anti-CD3 antibody used in allograft rejection is associated with diminished release of pro-inflammatory cytokinesI C Abbs, M Clark, H Waldmann, et al.
Pageof 6